Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus

Abstract Introduction Several systemic therapies have been approved for the treatment of severe AD. In particular, Janus kinase inhibitors (JAKi), including abrocitinib, baricitinib, and upadacitinib, recently received approval for the treatment of patients with severe AD after being evaluated in se...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Luigi Gargiulo (Yazar), Luciano Ibba (Yazar), Piergiorgio Malagoli (Yazar), Anna G. Burroni (Yazar), Andrea Chiricozzi (Yazar), Paolo Dapavo (Yazar), Silvia M. Ferrucci (Yazar), Massimo Gola (Yazar), Maddalena Napolitano (Yazar), Michela Ortoncelli (Yazar), Maria T. Rossi (Yazar), Claudio Sciarrone (Yazar), Antonio Costanzo (Yazar), Alessandra Narcisi (Yazar)
Materyal Türü: Kitap
Baskı/Yayın Bilgisi: Adis, Springer Healthcare, 2024-03-01T00:00:00Z.
Konular:
Online Erişim:Connect to this object online.
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Internet

Connect to this object online.

3rd Floor Main Library

Detaylı Erişim Bilgileri 3rd Floor Main Library
Yer Numarası: A1234.567
Kopya Bilgisi 1 Kütüphanede